DIPROSTENE, suspension for injection in a pre-filled syringe syringe, 1 ml
Active ingredients: Betamethasone, Betamethasone sodium phosphate, Betamethasone dipropionate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Suspension for injectionsyringe, 1 mlendosinusale;intraarticulaire;intralésionnelle;intramusculaire;périarticulaire
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- DIPROSTENE, suspension injectable en seringue pré-remplie
- Pharmaceutical form
- suspension injectable
- Route of administration
- endosinusale;intraarticulaire;intralésionnelle;intramusculaire;périarticulaire
- Presentation description
- 1 seringue(s) préremplie(s) de 1 ml en verre avec aiguille(s)
- Marketing authorisation holder
- ORGANON FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1977
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68163833CIP73200509CIP133400932005093Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉTAMÉTHASONEsuspension | 2 mg · 1 ml de suspension injectable | FT |
| BÉTAMÉTHASONEsuspension | 5 mg · 1 ml de suspension injectable | FT |
| BÉTAMÉTHASONE (PHOSPHATE DISODIQUE DE)suspension | 2,63 mg · 1 ml de suspension injectable | SA |
| DIPROPIONATE DE BÉTAMÉTHASONEsuspension | 6,43 mg · 1 ml de suspension injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.